LRP1 is increasingly recognised for its central role in protection against cardiovascular disease, with mutations in the gene now implicated through genome-wide association studies as a causal factor in AAA [17], carotid artery [18] and coronary artery disease [19]. The gene discussed is LRP1; the disease is triple-A syndrome.